Neurosurgery
The Stanford Cyberknife Program

Stanford CyberKnife Clinical Trials

A Novel Drug to Enhance Stereotactic Radiosurgery - Treatment of Brain Metastasis from Lung Cancer
Status: Recruiting Now

A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia
Principal Investigator: Scott G. Soltys, MD
Status: Recruiting Now

A Study of Patient Reported Outcomes After Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia
Principal Investigator: Scott G. Soltys, MD
Status: Recruiting Now

Can You Have Pain Relief Without Side Effects?
Status: Recruiting Now

Diffusion Tensor Imaging Magnetic Resonance Imaging (DTI MRI) as a Correlate to Pain Relief and Facial Numbness in Patients Following Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia
Principal Investigator: Scott G. Soltys, MD
Status: Recruiting Now

How Does CyberKnife Radiosurgery Relieve Pain?
Status: Recruiting Now

Multi-Session Radiosurgery for Large Brain Metastasis
Status: Recruiting Now

Phase I Compare OS in Post-CyberKnife Radiosurgery Tx in 1-3 VS 4 or More Brain Metastases
Principal Investigator: Steven D. Chang, MD
Status: Recruiting Now

Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer
Principal Investigator: Griffith Harsh, MD
Status: Recruiting Now

Phase I/II Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
Principal Investigator: Scott G. Soltys, MD
Status: Recruiting Now

Radiosurgical Neuromodulation for Refractory Depression
Principal Investigator: John R. Adler, MD
Status: Recruiting Now

 

Clinical Trials Coordinator

Maria Coburn (650) 736-9551

 

 

Footer Links: